首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備

市場調查報告書

商品編碼

1741411

救援吸入器市場：按產品類型、適應症、患者類型、劑型、最終用戶和地區分類

Rescue Inhaler Market, By Product Type, By Indication, By Patient Type, By Dosage Form, By End User, By Geography

出版日期: 2025年03月27日 | 出版商:

Coherent Market Insights | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

救援吸入器市場規模預計在 2025 年達到 199.5 億美元，預計到 2032 年將達到 360 億美元，2025 年至 2032 年的年複合成長率為 8.8%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	199.5億美元
效能數據	從2020年到2024年	預測期	2025年至2032年
預測期：2025-2032年年複合成長率：	8.80%	2032年價值預測	360億美元

急救吸入器，也稱為緩解吸入器，是氣喘和慢性阻塞性肺病(COPD) 等呼吸系統疾病患者常用的藥物設備。它們含有速效支氣管擴張劑，可在氣喘發作或呼吸困難時擴張氣道。這種藥物可以快速緩解喘息、呼吸急促和胸悶等症狀。雖然急救吸入器可以快速緩解症狀，但它們並不能治療症狀的根本原因。它們是控制急性呼吸道症狀和改善患者生活品質的重要工具。

市場動態：

預計呼吸系統疾病盛行率上升、老年人口成長以及醫療保健支出上漲將在預測期內推動全球急救吸入器市場的成長。此外，技術進步也有望在預測期內推動全球急救吸入器市場的成長。新興市場的高成長潛力、居家照護環境需求的不斷成長、氣喘生技藥品的開發以及對呼吸照護遠端醫療日益成長的關注，預計將在預測期內為全球急救吸入器市場帶來成長機會。

然而，嚴格的監管要求、吸入器的副作用以及吸入器的高成本預計將在預測期內阻礙救援吸入器市場的成長。

本研究的主要特點

本報告對救援吸入器市場進行了詳細分析，並提供了預測期 2025-2032 的市場規模和年複合成長率（CAGR%），假設 2024 年為基準年。
它揭示了不同領域的潛在商機，並解釋了該市場的有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
它根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數，介紹了救援吸入器市場的主要企業概況。
本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
救援吸入器市場報告迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
相關人員將透過用於分析救援吸入器市場的各種戰略矩陣更輕鬆地做出決策。

市場動態
- 驅動程式
呼吸系統疾病盛行率上升
人口老化加劇
提高產品核可
- 限制因素
嚴格的監管要求
產品召回
吸入器高成本
- 機會
遠端醫療在呼吸照護領域獲得青睞
氣喘生物製藥的開發
新興市場具有高成長潛力
影響分析
主要亮點
監管情景
產品發布/核准
PEST分析
波特分析
併購場景

4. 救援吸入器市場-冠狀病毒（COVID-19）大流行的影響

COVID-19流行病學
供需側分析
經濟影響

5. 2020 年至 2032 年救援吸入器市場（依產品類型）

定量噴霧吸入器
乾粉吸入器
噴霧器
緩霧吸入器
其他

6. 救援吸入器市場（依適應症分類），2020 年至 2032 年

氣喘
COPD
過敏性鼻炎
肺動脈高血壓
其他

7. 救援吸入器市場（依病患類型），2020 年至 2032 年

成人
孩子們

8. 救援吸入器市場（依劑型分類），2020-2032 年

膠囊
液體
暫停
其他

9. 2020 年至 2032 年救援吸入器市場（依最終使用者分類）

居家醫療
醫院和診所

第 10 章。 2020 年至 2032 年按地區分類的救援吸入器市場

北美洲
歐洲
亞太地區
拉丁美洲
中東
非洲

第11章競爭格局

GSK plc.
Teva Pharmaceutical Industries Ltd.
Cipla Inc.
PARI Pharma GmbH
Lupin
AstraZeneca
Boehringer Ingelheim International GmbH.
Novartis
Pfizer
Sunovion Pharmaceuticals
3M
OMRON Healthcare Co., Ltd.
Koninklijke Philips NV
Invacare
Schiller
Teleflex Incorporated

第12章章節

調查方法
關於出版商

簡介目錄

Product Code: CMI6208

Rescue Inhaler Market is estimated to be valued at USD 19.95 Bn in 2025 and is expected to reach USD 36 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.8% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 19.95 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	8.80%	2032 Value Projection:	USD 36 Bn

A rescue inhaler, also known as a reliever inhaler, is a medication device commonly used by individuals with respiratory conditions such as asthma or chronic obstructive pulmonary disease (COPD). It contains a fast-acting bronchodilator medication that helps open up airways during an asthma attack or breathing difficulties. This medication quickly eases symptoms like wheezing, shortness of breath, and chest tightness. Rescue inhalers offer rapid relief, but they do not treat the underlying cause of the condition. They are an essential tool for managing acute respiratory symptoms and improving the patient's quality of life.

Market Dynamics:

Rising prevalence of respiratory diseases, increasing geriatric population, and rising healthcare expenditure are anticipated to drive growth of the global rescue inhaler market over the forecast period. Moreover, technological advancements is also expected to boost the growth of the global rescue inhaler market over the forecast period. High growth potential in emerging markets, growing demand for home care settings, development of biologics for asthma, rising focus on telehealth for respiratory care are expected to create growth opportunities for the global rescue inhaler market during the forecast period.

However, stringent regulatory requirements, side effects of inhalers, and high cost of inhalers are expected to hamper growth of the rescue inhaler market over the forecast period.

Key features of the study:

This report provides an in-depth analysis of the rescue inhaler market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the rescue inhaler market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include GSK plc., Teva Pharmaceutical Industries Ltd., Cipla Inc., PARI Pharma GmbH, Lupin, AstraZeneca, Boehringer Ingelheim International GmbH., Novartis, Pfizer, Sunovion Pharmaceuticals, 3M, OMRON Healthcare Co., Ltd., Koninklijke Philips N.V., Schiller, and Teleflex Incorporated
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The rescue inhaler market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the rescue inhaler market

Rescue Inhaler Market Detailed Segmentation:

By Product Type:
- Metered Dose Inhalers
- Dry Powder Inhalers
- Nebulizers
- Soft Mist Inhalers
- Others
By Indication:
- Asthma
- COPD
- Allergic Rhinitis
- Pulmonary Arterial Hypertension
- Others
By Patient Type:
- Adult
- Pediatric
By Dosage Form:
- Capsules
- Solution
- Suspension
- Others
By End User:
- Home Care Settings
- Hospitals & Clinics
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profile:
- GSK plc.
- Teva Pharmaceutical Industries Ltd.
- Cipla Inc.
- PARI Pharma GmbH
- Lupin
- AstraZeneca
- Boehringer Ingelheim International GmbH.
- Novartis
- Pfizer
- Sunovion Pharmaceuticals
- 3M
- Omron Healthcare
- Koninklijke Philips N.V.
- Invacare
- Schiller
- Teleflex Incorporated

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Indication
- Market Snippet, By Patient Type
- Market Snippet, By Dosage Form
- Market Snippet, By End User
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
Rising prevalence of respiratory diseases
Increasing geriatric population
Increasing Product Approval
- Restraints
Stringent regulatory requirements
Product Recall
High cost of inhalers
- Opportunities
Rising focus on telehealth for respiratory care
Development of biologics for asthma
High growth potential in emerging markets
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Rescue Inhaler Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Rescue Inhaler Market, By Product Type, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Metered Dose Inhalers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Dry Powder Inhalers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Nebulizers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Soft Mist Inhalers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

6. Rescue Inhalers Market, By Indication, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Asthma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
COPD
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Allergic Rhinitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Pulmonary Arterial Hypertension
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

7. Rescue Inhalers Market, By Patient Type, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

8. Rescue Inhalers Market, By Dosage Form, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Capsules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Solution
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Suspension
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

9. Rescue Inhalers Market, By End User, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Home Care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Hospitals & Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

10. Rescue Inhalers Market, By Region, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, By Country, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Country 2021 -2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - UK
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Bn)
  - North Africa
  - South Africa
  - Central Africa

11. Competitive Landscape

GSK plc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Cipla Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
PARI Pharma GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Lupin
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Boehringer Ingelheim International GmbH.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Novartis
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Pfizer
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Sunovion Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
3M
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
OMRON Healthcare Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Koninklijke Philips N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Invacare
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Schiller
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Teleflex Incorporated
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views